Yeast model offers clues to possible drug targets for Lou Gehrig's disease, study shows
Sunday, October 28, 2012 - 13:50
in Health & Medicine
Amyotrophic lateral sclerosis, also called Lou Gehrig's disease, is a devastatingly cruel neurodegenerative disorder that robs sufferers of the ability to move, speak and, finally, breathe. Now researchers have used baker's yeast -- a tiny, one-celled organism -- to identify a chink in the armor of the currently incurable disease that may eventually lead to new therapies for human patients.